Literature DB >> 10835425

The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max.

H Wang1, C Liu, Y Lu, G Chatterjee, X Y Ma, R N Eisenman, P Lengyel.   

Abstract

p202a is a murine protein that is induced during the fusion of myoblasts to myotubes and can also be induced by interferon. Even 2-3-fold overexpression of p202a in cells retards proliferation. p202a was shown to modulate transcription by binding, and inhibiting the activity of several transcription factors including c-Fos, c-Jun, AP-2, E2F1, E2F4, NF-kappaB, MyoD, and myogenin. Here we report that p202a also bound the c-Myc protein in vitro and in vivo; the C-terminal p202a b segment bound the C-terminal basic region helix-loop-helix-leucine zipper (bHLHLZ) region of c-Myc. The transfection of a p202a expression plasmid inhibited the c-Myc-dependent expression of reporter plasmids in transient assays; moreover, overexpression of p202a in stable cell lines decreased the endogenous levels of mRNAs whose expression is driven by c-Myc. These effects of p202a are consistent with our finding that the binding of p202a to c-Myc inhibited the binding of c-Myc to Max in vitro and in vivo. p202a also inhibited the c-Myc-induced anchorage-independent growth and apoptosis of Rat-1 cells. The inhibition of c-Myc-dependent transcription, proliferation, and apoptosis by p202a is in line with the involvement of p202a in differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835425     DOI: 10.1074/jbc.M003409200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.

Authors:  Chuan-ju Liu; Bo Ding; Hong Wang; Peter Lengyel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 3.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

4.  Wanderings in biochemistry.

Authors:  Peter Lengyel
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

Review 5.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

Review 6.  The p200 family protein p204 as a modulator of cell proliferation and differentiation: a brief survey.

Authors:  Peter Lengyel; C J Liu
Journal:  Cell Mol Life Sci       Date:  2009-11-18       Impact factor: 9.261

7.  Inflammation activates the interferon signaling pathways in taste bud cells.

Authors:  Hong Wang; Minliang Zhou; Joseph Brand; Liquan Huang
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

8.  Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway.

Authors:  Jianming Chen; Ravichandran Panchanathan; Divaker Choubey
Journal:  Immunol Lett       Date:  2008-03-13       Impact factor: 3.685

Review 9.  p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation.

Authors:  Yi Luan; Peter Lengyel; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2008-11-21       Impact factor: 7.638

10.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.